Antigenics Success in Russia, Also a 'Personalized' Win

Personalized medicine became more than a buzzword two weeks ago. When the Russian Ministry of Public Health approved Oncophage, Antigenics Inc.'s cancer vaccine, it marked the first such approval for a personalized vaccine from a major country, and it shines new light on that system of disease treatment and management. (BioWorld Financial Watch)